CD4 and neoplasm: However, studies have shown that CD69 is linked to T‐cell exhaustion and increased tumor progression.[25, 36] Therefore, using CD69 as the only T cell activation marker may not be sufficient to determine whether CD4+ Jurkat T cells are activated.